GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Esr2 | decreases expression | ISO | ESR2 (Homo sapiens) | 6480464 | CTD | Cisplatin results in decreased expression of ESR2 mRNA | PMID:23956100 | Esr2 | increases response to substance | ISO | ESR2 (Homo sapiens) | 6480464 | CTD | ESR2 protein results in increased susceptibility to Cisplatin | PMID:20623183 | Esr2 | multiple interactions | ISO | ESR2 (Homo sapiens) | 6480464 | CTD | ESR2 protein inhibits the reaction [Cisplatin results in increased expression of and results in increased phosphorylation of CDC25C protein]; ESR2 protein inhibits the reaction [Cisplatin results in increased expression of BRCA1 mRNA]; ESR2 protein inhibits the reaction [Cisplatin results in increased expression of BRCA1 protein]; ESR2 protein inhibits the reaction [Cisplatin results in increased phosphorylation of CHEK1 protein]; ESR2 protein promotes the reaction [Cisplatin results in increased expression of CASP2 protein]; ESR2 protein promotes the reaction [Cisplatin results in increased expression of CASP3 protein]; TP53 protein inhibits the reaction [ESR2 protein results in increased susceptibility to Cisplatin] | PMID:20623183 | |
Go Back to source page | Continue to Ontology report |